Actuate Therapeutics, Inc. (ACTU) Ratios
55 Followers
Actuate Therapeutics, Inc. Ratios
ACTU's free cash flow for Q2 2026 was $-4.41M. For the 2026 fiscal year, ACTU's free cash flow was increased by $3.00 and operating cash flow was $-4.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 2.39 | 1.05 | 0.43 | 4.71 |
| Quick Ratio | 2.39 | 1.05 | 0.43 | 4.71 |
| Cash Ratio | 2.31 | 0.98 | 0.43 | 4.71 |
| Solvency Ratio | -3.64 | -2.73 | -0.24 | -3.56 |
| Operating Cash Flow Ratio | -3.37 | -2.48 | -3.12 | -4.10 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 7.53M | $ -6.36K | $ -99.63M | $ 14.83M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.03 | 0.00 | 0.00 | 0.02 |
| Debt-to-Equity Ratio | 0.05 | 0.00 | 0.00 | 0.03 |
| Debt-to-Capital Ratio | 0.05 | 0.00 | 0.00 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.00 | 0.00 | 0.03 |
| Financial Leverage Ratio | 1.77 | 89.44 | -0.03 | 1.38 |
| Debt Service Coverage Ratio | -1096.67 | 1344.31 | -559.75 | -1239.48 |
| Interest Coverage Ratio | -1110.88 | 1344.27 | -572.26 | -1247.33 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | -0.00 | 0.00 | 0.03 |
| Net Debt to EBITDA | 0.57 | 0.34 | 0.12 | 1.00 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.81% | 108.44% | 99.08% | 99.77% |
| Return on Assets (ROA) | -158.36% | -292.81% | -826.04% | -98.42% |
| Return on Equity (ROE) | -280.51% | -26189.05% | 24.84% | -135.92% |
| Return on Capital Employed (ROCE) | -270.08% | -4876.63% | 636.27% | -125.21% |
| Return on Invested Capital (ROIC) | -270.08% | -4876.63% | 636.27% | -125.21% |
| Return on Tangible Assets | -158.36% | -292.81% | -826.04% | -98.42% |
| Earnings Yield | -17.28% | -17.57% | -19.12% | -15.57% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.91 | -1.12 | -1.44 | -1.18 |
| Free Cash Flow Per Share | -0.91 | -1.12 | -1.44 | -1.18 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -47.42 | 0.00 | 0.00 | -43.94 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -14.93% | -14.06% | -16.71% | -13.75% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -5.77 | -2.44 | -5.23 | -6.42 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 16.24 | 1490.96 | -1.30 | 8.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.70 | -7.11 | -5.99 | -7.27 |
| Price-to-Operating Cash Flow Ratio | -6.70 | -7.11 | -5.99 | -7.27 |
| Price-to-Earnings Growth (PEG) Ratio | 0.09 | -0.03 | -0.23 | 0.00 |
| Enterprise Value Multiple | -5.22 | -5.83 | -5.18 | -5.45 |
| Enterprise Value | 115.90M | 146.70M | 126.48M | 109.40M |
| EV to EBITDA | -5.22 | -5.83 | -5.18 | -5.45 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -6.03 | -6.72 | -5.85 | -6.15 |
| EV to Operating Cash Flow | -6.03 | -6.72 | -5.85 | -6.15 |
| Tangible Book Value Per Share | 0.38 | 0.01 | -6.63 | 0.99 |
| Shareholders’ Equity Per Share | 0.38 | 0.01 | -6.63 | 0.99 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.06 | -1.40 | -1.65 | -1.34 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.86 | 0.80 | 0.87 | 0.88 |
Currency in USD
